Dr. Balmaceda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
350 Fort Washington Ave
New York, NY 10033Phone+1 917-326-0834Fax+1 314-405-9598
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1988 - 1991
Albert Einstein College of Medicine/Montefiore (New Rochelle)Internship, Transitional Year, 1987 - 1988
Columbia University Vagelos College of Physicians and SurgeonsClass of 1987
Certifications & Licensure
NY State Medical License 1991 - 2026
NJ State Medical License 2021 - 2025
CT State Medical License 2011 - 2012
RI State Medical License 2011 - 2012- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma Start of enrollment: 2000 Feb 01
Publications & Presentations
PubMed
- 149 citationsProspective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing.Peter A. Forsyth, Casilda Balmaceda, Kendra Peterson, Andrew D. Seidman, Penny M. A. Brasher
Journal of Neuro-Oncology. 1997-10-01 - 154 citationsMa1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders.Josep Dalmau, S. Humayun Gultekin, Raymond Voltz, Rita Hoard, Thomas DesChamps
Brain. 1999-01-01 - 51 citationsNevus of Ota and leptomeningeal melanocytic lesionsCasilda Balmaceda, Michael R. Fetell, James M. Powers, Joseph L. O'Brien, E. H. Housepian
Neurology. 1993-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
